Methocarbamol

Overview

Methocarbamol is a centrally acting muscle relaxant used to treat skeletal muscle spasms. It is often used in conjunction with rest and physical therapy to treat acute, painful musculoskeletal conditions.

API suppliers (24)

Suppliers of Methocarbamol evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• Zhejiang Haizhou Pharmaceutical Co., Ltd.China2 active DMF
• Seven Star Pharmaceutical Co., Ltd.Taiwan1 active DMF
• SYNTHOKEM LABS PRIVATE LTDIndia1 active DMF
• BOEHRINGER INGELHEIM CHEMICALS INC1 active DMF
• Granules India LimitedIndia1 active DMF GMP on record
• DELTA SYNTHETIC CO LTDTaiwan1 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
• HEXAGON LABORATORIES INC
• Cipla USA, Inc.USA
• PENCO OF LYNDHURST INC
• TIANJIN MEDICINES & HEALTH PRODUCTS IMPORT AND EXPORT CO
• BIDACHEM SPAItaly GMP on record
• BENTLEY API SL
• ZHEJIANG JIANFENG HAIZHOU PHARMACEUTICAL CO LTD
• CHRISTIAN BRUNNENGRABER AND CO
• Orion CorporationFinland
• CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD GMP on record
• SIANG TA PHARMACEUTICAL CO LTD
• SYNTHA
• ORGAMOL SA
• EASTMAN CHEMICAL COUnited States
• LASA LABORATORIOS SA
• ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
• OMNICHEM NV

Patent & exclusivity (US)

Per the FDA Orange Book (30 approved US products), the latest listed US patent on Methocarbamol expires 9 Oct 2044. Generic API sourcing typically opens up once these lapse.

Therapeutic areas